TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8645511

Group type: EXPERIMENTAL
Intervention: Sequential treatment with prednisone for 6 weeks followed by alpha‐2a interferon (IFN) for 6 months (group A)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Concomitant administration of prednisone and IFN (group B)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Group A (anti-HBe patients)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Group B (anti-HBe patients)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Overall treatment response
Number of subjects: 18
Study: 1536049

Group type: COMPARATOR
Intervention: Verapamil therapy (120 mg thrice daily)
Number of subjects: 1595

Group type: COMPARATOR
Intervention: Verapamil therapy (360 mg daily)
Number of subjects: 1595
Study: 6678823

Group type: EXPERIMENTAL
Intervention: Domifen bromide in combination with antibiotics
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 29103528

Group type: EXPERIMENTAL
Intervention: Adaptive n-back working memory training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control task
Number of subjects: 0
Study: 27488183

Group type: EXPERIMENTAL
Intervention: Yam bean root juice (500 ml)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Guava fruit juice (500 ml)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water (500 ml)
Number of subjects: 30
Study: 24706693

Group type: EXPERIMENTAL
Intervention: Video instruction
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Faculty-led hands-on instruction
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both video and hands-on instruction
Number of subjects: 30
Study: 22350254

Group type: EXPERIMENTAL
Intervention: Moxifloxacin
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 19752016

Group type: EXPERIMENTAL
Intervention: Direct bonding method (Group 1)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Indirect bonding method with Transbond XT and Sondhi Rapid Set A/B Primer (Group 2)
Number of subjects: 40
Study: 18297259

Group type: EXPERIMENTAL
Intervention: Brisk walking (3 times a week for 60 min)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Medical fitness programme
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Brisk walking
Number of subjects: 92
Study: 15994614

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fascia lata
Number of subjects: 100
Study: 12909502

Group type: EXPERIMENTAL
Intervention: Subcutaneous unfractionated heparin (5000 IU b.i.d.) and aspirin (100 mg daily)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 11865427

Group type: EXPERIMENTAL
Intervention: 3 doses of subunit CMV glycoprotein B (gB) vaccine plus MF59
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 2 doses of canarypox recombinant vaccine expressing CMVgB (ALVAC-CMVgB) followed by 2 doses of the subunit gB vaccine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: 3 doses of both vaccines administered concomitantly
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study: 11501128

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-HBOT
Number of subjects: 42
Study: 7494621

Group type: EXPERIMENTAL
Intervention: alpha-linolenic acid-enriched diet
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prudent diet of the American Heart Association (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group overall mortality
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Experimental group overall mortality
Number of subjects: 0
Study: 2228923

Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.3 mg/kg
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Methylphenidate 0.6 mg/kg
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Methylphenidate (both doses)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 11

Group type: COMPARATOR
Intervention: Parent instruments
Number of subjects: 11
Study: 6996341

Group type: EXPERIMENTAL
Intervention: Sulfametrol-trimethoprim (Lidaprim)
Number of subjects: 20
Study: 31806413

Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP) for 3 months
Number of subjects: 301

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 301
Study: 30704982

Group type: EXPERIMENTAL
Intervention: Glucose solution
Number of subjects: 30

Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study: 27180818

Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise intervention
Number of subjects: 153

Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 153
Study: 25887302

Group type: EXPERIMENTAL
Intervention: Occupational medicine intervention
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 300
Study: 24171490

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 2218

Group type: COMPARATOR
Intervention: Control (unfractionated or low-molecular-weight heparin with optional glycoprotein IIb/IIIa inhibitors)
Number of subjects: 2218
Study: 20399573

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 19255200

Group type: EXPERIMENTAL
Intervention: Two-incision total hip arthroplasty
Number of subjects: 72

Group type: COMPARATOR
Intervention: Mini-posterior-incision total hip arthroplasty
Number of subjects: 72
Study: 17355268

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 1823

Group type: COMPARATOR
Intervention: Placebo or Nontreatment
Number of subjects: 1823
Study: 15382303

Group type: EXPERIMENTAL
Intervention: CMT with surgery and chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery after chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgery for mixed-histology cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Repeat biopsy
Number of subjects: 0
Study: 11500255

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 9058513

Group type: EXPERIMENTAL
Intervention: Cyclic regimen of interferon alpha‐2b (IFN‐alpha) at a dose of 10 MU/m2 body surface subcutaneously on 5 consecutive days every 4 weeks
Number of subjects: 23
Study: 7937245

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2851388

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 40
Study: 31198105

Group type: EXPERIMENTAL
Intervention: Lifting straps (WS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Without lifting straps (WOS)
Number of subjects: 12
Study: 30196869

Group type: EXPERIMENTAL
Intervention: Strongest Families Smart Website (SFSW) intervention
Number of subjects: 464

Group type: COMPARATOR
Intervention: Educational Control (EC)
Number of subjects: 464
Study: 27616628

Group type: COMPARATOR
Intervention: BT (36-session group Internet behavioral weight control treatment)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: BT + MI (36-session group Internet behavioral weight control treatment + 6 individual MI chat sessions)
Number of subjects: 398
Study: 24443783

Group type: EXPERIMENTAL
Intervention: CHANGE intervention schools
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control schools
Number of subjects: 8
Study: 21334858

Group type: EXPERIMENTAL
Intervention: Multifamily Group Psychoeducation
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Solution Focussed Group Therapy
Number of subjects: 47

Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 47
Study: 20482930

Group type: EXPERIMENTAL
Intervention: Low-fat intake (LOFAT)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: High intake of fruits and vegetables (HIFV)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Comparison between LOFAT and HIFV
Number of subjects: 68
Study: 18777606

Group type: EXPERIMENTAL
Intervention: Combination of static and dynamic magnetic fields (PEMF) applied 4 hours/day for 2 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham treatment (placebo)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Active PEMF exposure (after 2 months)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 36
Study: 16108731

Group type: EXPERIMENTAL
Intervention: IFN-beta1a
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IFN-beta1a + pentoxifylline (PTX)
Number of subjects: 0
Study: 15636358

Group type: EXPERIMENTAL
Intervention: External Qi-therapy (EQT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 10
Study: 10763797

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise in the gym
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Home exercise
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 90
Study: 8769692

Group type: EXPERIMENTAL
Intervention: Interferon-alpha (IFN-alpha)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Conventional chemotherapy
Number of subjects: 600
Study: 1564153

Group type: EXPERIMENTAL
Intervention: Penicillin or erythromycin for 14 days with placebo added during the last 5 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Penicillin or erythromycin for 14 days with rifampin added during the last 5 days
Number of subjects: 20
Study: 4074614

Group type: EXPERIMENTAL
Intervention: Diltiazem 60 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diltiazem 120 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Diltiazem 180 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3481635

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg) during sodium repletion (100 mmol/day)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg) during sodium depletion (20 mmol/day)
Number of subjects: 11
Study: 30514657

Group type: EXPERIMENTAL
Intervention: Serious game 'Stop bullying now!', played for 20 minutes
Number of subjects: 150

Group type: COMPARATOR
Intervention: Active control group, digital information package about bullying
Number of subjects: 150

Group type: COMPARATOR
Intervention: Passive control group, digital information package not related to bullying
Number of subjects: 150
Study: 28492198

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (Fluor Protector)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine varnish (Cervitec Plus)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10% Povidone-iodine (PI)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study: 25540221

Group type: EXPERIMENTAL
Intervention: Testosterone
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 23296954

Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion
Number of subjects: 6

Group type: COMPARATOR
Intervention: Sodium bicarbonate (NaHCO3) ingestion
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion during exercise
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sodium acetate (NaAc) ingestion during final 75 min of exercise
Number of subjects: 6
Study: 22332570

Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wait-and-see (group WS)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T1 cases
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T1 cases
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T2 cases
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T2 cases
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for T2b cases (size > 3.0 cm)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for T2b cases (size > 3.0 cm)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Neck dissection (group ND) for pathologically poor differentiation cases
Number of subjects: 132

Group type: COMPARATOR
Intervention: Wait-and-see (group WS) for pathologically poor differentiation cases
Number of subjects: 132
Study: 18281192

Group type: EXPERIMENTAL
Intervention: Non-Criterion A1 events
Number of subjects: 119

Group type: COMPARATOR
Intervention: Criterion A1 events
Number of subjects: 119
Study: 16808576

Group type: EXPERIMENTAL
Intervention: LED curing devices with soft start mode
Number of subjects: 20

Group type: COMPARATOR
Intervention: Halogen light curing technique
Number of subjects: 20
Study: 12393110

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine (1-1.5 mg/kg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol-fentanyl (3-5 microg/kg)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Propofol-ketamine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Propofol-fentanyl
Number of subjects: 120
Study: 10326078

Group type: EXPERIMENTAL
Intervention: Bootstrapping methodology for estimating confidence intervals for cost-effectiveness ratios
Number of subjects: 0
Study: 7843782

Group type: COMPARATOR
Intervention: 20 mg enalapril once daily in the morning for 5 days
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 79
Study: 2162692

Group type: EXPERIMENTAL
Intervention: Daily diary card during chemotherapy
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Comparison with nurse ratings, EORTC questionnaire, Spitzer quality of life index
Number of subjects: 53
Study: 412877

Group type: EXPERIMENTAL
Intervention: Intramuscular meptazinol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pentazocine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29925090

Group type: EXPERIMENTAL
Intervention: 17 alpha-hydroxyprogesterone caproate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27682642

Group type: EXPERIMENTAL
Intervention: Bipolar vessel-sealing device (BVSD)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Ultrasonically activated device (UAD)
Number of subjects: 380

Group type: COMPARATOR
Intervention: Control group (no energy device used)
Number of subjects: 380
Study: 25456014

Group type: EXPERIMENTAL
Intervention: Intervention aimed at increasing colorectal cancer (CRC) screening
Number of subjects: 5628

Group type: COMPARATOR
Intervention: Control group (not explicitly detailed in the abstract)
Number of subjects: 5628
Study: 22868780

Group type: EXPERIMENTAL
Intervention: Patient-specific guides (PSG)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Computer-assisted navigation (CAN)
Number of subjects: 111
Study: 20610229

Group type: EXPERIMENTAL
Intervention: Transient worsening renal function (WRF)
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Persistent worsening renal function (WRF)
Number of subjects: 467

Group type: COMPARATOR
Intervention: Stable renal function
Number of subjects: 467

Group type: EXPERIMENTAL
Intervention: Transient WRF vs. Persistent WRF
Number of subjects: 467
Study: 19040004

Group type: EXPERIMENTAL
Intervention: Spinal navigation with intra‐operative 3D‐imaging system
Number of subjects: 401

Group type: COMPARATOR
Intervention: Traditional method of pedicle screw fixation
Number of subjects: 401
Study: 17262997

Group type: EXPERIMENTAL
Intervention: High levels of Fas mRNA in RR MS patients (n=13)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: High levels of FasL mRNA in SP MS patients (n=12)
Number of subjects: 25
Study: 14662245

Group type: EXPERIMENTAL
Intervention: Abciximab plus IRA stenting
Number of subjects: 400

Group type: COMPARATOR
Intervention: Stent only
Number of subjects: 400
Study: 10541446

Group type: COMPARATOR
Intervention: Daily supplementation with antioxidant vitamins (vitamin C, 120 mg, vitamin E, 30 mg, beta‐carotene, 6 mg) and minerals (selenium, 100 microg, and zinc, 20 mg)
Number of subjects: 12735

Group type: COMPARATOR
Intervention: Daily supplementation with antioxidant vitamins and minerals
Number of subjects: 12735
Study: 8902310

Group type: EXPERIMENTAL
Intervention: Days with mean temperature > 20 degrees C
Number of subjects: 2877

Group type: COMPARATOR
Intervention: Days with temperature < or = 20 degrees C
Number of subjects: 2877
Study: 1684314

Group type: EXPERIMENTAL
Intervention: GHRH after saline infusion (Day 2)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Somatostatin infusion followed by saline (Day 3)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: GHRH with somatostatin withdrawal (Day 4)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline infusion (Day 1)
Number of subjects: 7
Study: 6750779

Group type: EXPERIMENTAL
Intervention: Microencapsulated acetylsalicylic acid (ASA) with pH-dependent release (Reumyl)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Microencapsulated acetylsalicylic acid (ASA) with time-dependent release (Acetard)
Number of subjects: 18
Study: 31701388

Group type: EXPERIMENTAL
Intervention: You-Me-Us healthy relationship program
Number of subjects: 911

Group type: COMPARATOR
Intervention: Control group (not explicitly defined)
Number of subjects: 911
Study: 30002007

Group type: EXPERIMENTAL
Intervention: Best usual primary care plus treatment with oseltamivir for 5 days
Number of subjects: 2500

Group type: COMPARATOR
Intervention: Best usual primary care
Number of subjects: 2500
Study: 27936189

Group type: EXPERIMENTAL
Intervention: Peppy comments from attending physicians (e.g., 'Hope you have a quiet day!')
Number of subjects: 25

Group type: COMPARATOR
Intervention: No peppy comments from attending physicians (control group)
Number of subjects: 25
Study: 24793658

Group type: EXPERIMENTAL
Intervention: H‐NPPV
Number of subjects: 64

Group type: COMPARATOR
Intervention: IMV
Number of subjects: 64
Study: 22286847

Group type: EXPERIMENTAL
Intervention: Optimists (defined by Life Orientation Test - Revised)
Number of subjects: 284

Group type: EXPERIMENTAL
Intervention: Pessimists (defined by Life Orientation Test - Revised)
Number of subjects: 284

Group type: COMPARATOR
Intervention: Depressed patients
Number of subjects: 284
Study: 20146365

Group type: EXPERIMENTAL
Intervention: Inhaled tobramycin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Systemic antibiotics (intravenous ceftazidime and tobramycin)
Number of subjects: 15
Study: 18953269

Group type: EXPERIMENTAL
Intervention: Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New NNRTIs
Number of subjects: 0
Study: 15898539

Group type: EXPERIMENTAL
Intervention: Different texture types used in slant discrimination performance.
Number of subjects: 0
Study: 12913771

Group type: EXPERIMENTAL
Intervention: Tormentil root extract (3 drops per year of life, three times daily for up to 5 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (3 drops per year of life, three times daily for up to 5 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Tormentil root extract
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11783170

Group type: EXPERIMENTAL
Intervention: Yiqi Huoxue decoction (Group B)
Number of subjects: 62
Study: 8865768

Group type: EXPERIMENTAL
Intervention: Text presentation rate of 55 words/min
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Text presentation rate of 120 words/min
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Text presentation rate of 216 words/min
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Induced dioptric blur (0.5, 1.0, or 1.5 diopters)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Learning English as a second language
Number of subjects: 32
Study: 1511566

Group type: EXPERIMENTAL
Intervention: Acipimox (250 mg three times per day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 6421015

Group type: EXPERIMENTAL
Intervention: 1.6 mg NTG
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control (no NTG)
Number of subjects: 28
Study: 30824339

Group type: EXPERIMENTAL
Intervention: GHB (20 mg/kg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: GHB (35 mg/kg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 30243751

Group type: EXPERIMENTAL
Intervention: CRST (Cardiorespiratory Synchronization Training)
Number of subjects: 96

Group type: COMPARATOR
Intervention: RT (Relaxation Training)
Number of subjects: 96

Group type: COMPARATOR
Intervention: C (Control)
Number of subjects: 96
Study: 26389858

Group type: EXPERIMENTAL
Intervention: Mobile-based video clip on urinary catheterization (unlimited viewing for 1 week)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control group (no mobile-based video clip)
Number of subjects: 71
Study: 24974383

Group type: EXPERIMENTAL
Intervention: Post-stroke dementia and vascular dementia
Number of subjects: 90

Group type: COMPARATOR
Intervention: Post-stroke patients with no dementia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Post-stroke and vascular dementia
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dorsolateral prefrontal cortex pyramidal cells
Number of subjects: 90
Study: 22480799

Group type: EXPERIMENTAL
Intervention: Vitality diet (VD)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Healthy diet (HD)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 95
Study: 20416390

Group type: EXPERIMENTAL
Intervention: NVA237 100 microg
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: NVA237 200 microg
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 17651636

Group type: EXPERIMENTAL
Intervention: Management by minimization of the induced sputum EOS (Group A, n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Standard clinical guidelines (Group B, n = 21)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Group A
Number of subjects: 41

Group type: COMPARATOR
Intervention: Group B
Number of subjects: 41
Study: 15897211

Group type: EXPERIMENTAL
Intervention: Cognitive-oriented educational programme on assessment, treatment and management of somatisation (The Extended Reattribution and Management Model)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 43